Hou et al. propose a model whereby PRC2 and NuRD complexes are recruited by PHF20L1 binding to H3K27me2, resulting in transcriptional repression in the context of breast tumorigenesis (70). The gene discussed is PHF20L1; the disease is medical procedure.